Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism

Nature Communications

Volumn 7, Issue , 2016, Pages

  Greer, Renee L ^a   Dong, Xiaoxi ^a   Moraes, Ana Carolina F ^b   Zielke, Ryszard A ^a   Fernandes, Gabriel R ^c   Peremyslova, Ekaterina ^a   Vasquez Perez, Stephany ^a   Schoenborn, Alexi A ^d   Gomes, Everton P ^b   Pereira, Alexandre C ^b   Ferreira, Sandra R G ^b   Yao, Michael ^e   Fuss, Ivan J ^e   Strober, Warren ^e   Sikora, Aleksandra E ^a   Taylor, Gregory A ^f   Gulati, Ajay S ^d   Morgun, Andrey ^a   Shulzhenko, Natalia ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN; IFI1 PROTEIN, MOUSE;

ABUNDANCE; BACTERIUM; GENE EXPRESSION; GLUCOSE; IMMUNE SYSTEM; METABOLISM; RODENT;

AKKERMANSIA MUCINIPHILA; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL METABOLISM; CYTOKINE RELEASE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; INTESTINE FLORA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CARBOHYDRATE METABOLISM; GENE EXPRESSION; GENETICS; HUMAN; ILEUM; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; VERRUCOMICROBIA;

AKKERMANSIA MUCINIPHILA; MUS;

ANIMALS; CARBOHYDRATE METABOLISM; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION; GLUCOSE; GTP-BINDING PROTEINS; HUMANS; ILEUM; INTERFERON-GAMMA; MICE, INBRED C57BL; MICE, KNOCKOUT; VERRUCOMICROBIA;

EID: 84992113655     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms13329     Document Type: Article

References (68)

1. Donath, M. Y. & Shoelson, S. E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98-107 (2011).
2. Nishimura, S. et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15, 914-920 (2009).
3. Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184 (2007).
4. Feuerer, M. et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930-939 (2009).
5. Duffaut, C., Galitzky, J., Lafontan, M. & Bouloumie, A. Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem. Biophys. Res. Commun. 384, 482-485 (2009).
6. Wong, N. et al. Deficiency in interferon-gamma results in reduced body weight and better glucose tolerance in mice. Endocrinology 152, 3690-3699 (2011).
7. Rocha, V. Z. et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ. Res. 103, 467-476 (2008).
8. O'Rourke, R. W. et al. Systemic inflammation and insulin sensitivity in obese IFN-gamma knockout mice. Metabolism 61, 1152-1161 (2012).
9. Backhed, F. et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl Acad. Sci. USA 101, 15718-15723 (2004).
10. Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1131 (2006).
11. Vijay-Kumar, M. et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228-231 (2010).
12. Caricilli, A. M. et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol. 9, e1001212 (2011).
13. Shulzhenko, N. et al. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat. Med. 17, 1585-1593 (2011).
14. Everard, A. et al. Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat. Commun. 5, 5648 (2014).
15. Morgun, A. et al. Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks. Gut 64, 1732-1743 (2015).
16. Iida, N. et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342, 967-970 (2013).
17. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241 (2004).
18. Caesar, R. et al. Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice. Gut 61, 1701-1707 (2012).
19. Hwang, I. et al. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity. FASEB J. 29, 2397-2411 (2015).
20. Carvalho, B. M. et al. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 55, 2823-2834 (2012).
21. Membrez, M. et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J. 22, 2416-2426 (2008).
22. El Aidy, S. et al. Temporal and spatial interplay of microbiota and intestinal mucosa drive establishment of immune homeostasis in conventionalized mice. Mucosal Immunol. 5, 567-579 (2012).
23. Yambartsev, A. et al. Unexpected links reflect the noise in networks. Biol. Direct. doi: 10.1186/s13062-016-0155-0 (2016).
24. Derrien, M., Collado, M. C., Ben-Amor, K., Salminen, S. & de Vos, W. M. The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl. Environ. Microbiol. 74, 1646-1648 (2008).
25. Karlsson, C. L. et al. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity 20, 2257-2261 (2012).
26. Everard, A. et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110, 9066-9071 (2013).
27. Shin, N. R. et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63, 727-735 (2014).
28. Janeway, C. Immunobiology: The Immune System in Health and Disease 6th edn (Garland Science, 2005).
29. Mine, K. L. et al. Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer. Nat. Commun. 4, 1806 (2013).
30. Akavia, U. D. et al. An integrated approach to uncover drivers of cancer. Cell 143, 1005-1017 (2010).
31. Gerstein, M. B. et al. Architecture of the human regulatory network derived from ENCODE data. Nature 489, 91-100 (2012).
32. Santacruz, A. et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J. Nutr. 104, 83-92 (2010).
33. Teixeira, F. S. et al. Faecal levels of Bifidobacterium and Clostridium coccoides but not plasma lipopolysaccharide are inversely related to insulin and HOMA index in women. Clin. Nutr. 32, 1017-1022 (2013).
34. Zhang, X. et al. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS ONE 8, e71108 (2013).
35. Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60 (2012).
36. Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99-103 (2013).
37. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care 38, S8-S16 (2015).
38. de Almeida-Pititto, B. et al. Type 2 diabetes in Brazil: epidemiology and management. Diabetes Metab. Syndr. Obes. 8, 17-28 (2015).
39. Lee, H. & Ko, G. Effect of metformin on metabolic improvement and gut microbiota. Appl. Environ. Microbiol. 80, 5935-5943 (2014).
40. Dong, X. et al. Reverse enGENEering of regulatory networks from big data: a roadmap for biologists. Bioinform. Biol. Insights 61, 61-74 (2015).
41. Zhang, H., Sparks, J. B., Karyala, S. V., Settlage, R. & Luo, X. M. Host adaptive immunity alters gut microbiota. ISME J. 9, 770-781 (2015).
42. Taylor, G. A. IRG proteins: key mediators of interferon-regulated host resistance to intracellular pathogens. Cell. Microbiol. 9, 1099-1107 (2007).
43. Collazo, C. M. et al. Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection. J. Exp. Med. 194, 181-188 (2001).
44. Liu, B. et al. Irgm1-deficient mice exhibit Paneth cell abnormalities and increased susceptibility to acute intestinal inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 305, G573-G584 (2013).
45. Farin, H. F. et al. Paneth cell extrusion and release of antimicrobial products is directly controlled by immune cell-derived IFN-g. J. Exp. Med. 211, 1393-1405 (2014).
46. Canaan, A. et al. Extended lifespan and reduced adiposity in mice lacking the FAT10 gene. Proc. Natl Acad. Sci. USA 111, 5313-5318 (2014).
47. Sumarac-Dumanovic, M. et al. Therapeutic improvement of glucoregulation in newly diagnosed type 2 diabetes patients is associated with a reduction of IL-17 levels. Immunobiology 218, 1113-1118 (2013).
48. Pacifico, L. et al. Increased T-helper interferon-gamma-secreting cells in obese children. Eur. J. Endocrinol. 154, 691-697 (2006).
49. Schneeberger, M. et al. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci. Rep. 5, 16643 (2015).
50. Nath, N. et al. Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J. Immunol. 182, 8005-8014 (2009).
51. Forslund, K. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262-266 (2015).
52. Collado, M. C., Derrien, M., Isolauri, E., de Vos, W. M. & Salminen, S. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl. Environ. Microbiol. 73, 7767-7770 (2007).
53. Amann, R. I. et al. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl. Environ. Microbiol. 56, 1919-1925 (1990).
54. Du, P., Kibbe, W. A. & Lin, S. M. Lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547-1548 (2008).
55. Caporaso, J. G. et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 6, 1621-1624 (2012).
56. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335-336 (2010).
57. Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460-2461 (2010).
58. De Santis, T. Z. et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72, 5069-5072 (2006).
59. Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389-3402 (1997).
60. Schmieder, R. & Edwards, R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 27, 863-864 (2011).
61. Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114-2120 (2014).
62. Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111 (2009).
63. Anders, S., Pyl, P. T. & Huber, W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166-169 (2014).
64. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140 (2010).
65. Magoc, T. & Salzberg, S. L. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957-2963 (2011).
66. McDonald, D. et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 6, 610-618 (2011).
67. Mannon, P. J. et al. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency. Gastroenterology 131, 748-756 (2006).
68. Bonilla, F. A. et al. International Consensus Document (ICON): common variable immunodeficiency disorders. J. Allergy Clin. Immunol. Pract. 4, 38-59 (2016).